C
BIOREM Inc. BRM.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 118.64% -89.85% -92.87% 328.47% 456.81%
Total Depreciation and Amortization 44.24% 71.61% -30.89% 271.98% 33.74%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 77.32% -61.03% -193.68% 274.65% 364.39%
Change in Net Operating Assets 0.16% 16.62% 55.61% -106.85% 18.68%
Cash from Operations 30.36% 5.57% -4,380.85% 18.67% 40.08%
Capital Expenditure -6,566.67% 76.49% -104.17% 100.00% 99.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -6,566.67% 76.49% -104.17% 100.00% 99.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -10.06% 9.49% -32.79% 79.06% -2.78%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -8.77% 14.98% 127.20% 85.06% -951.37%
Foreign Exchange rate Adjustments -332.46% -143.60% -150.53% 337.36% -79.04%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 3.73% 14.16% -2,095.08% 315.52% 36.94%